Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiting Cao

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
NPJ Parkinson'S Disease|June 14, 2025
Perivascular space fluid diffusivity predicts clinical deterioration in prodromal and early-stage Parkinson's diseaseYi Xing, Miao Lin, Jingzhe Li, et al.
Cancer Research|October 19, 2005
Enhancement of cancer radiation therapy by use of adenovirus-mediated secretable glucose-regulated protein 94/gp96 expressionShanling Liu, He Wang, Zhonghui Yang, et al.
Cancer Research|April 19, 2007
Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growthYiting Cao, Pierre Sonveaux, Shanling Liu, et al.
Plos One|June 21, 2007
Erythropoietin blockade inhibits the induction of tumor angiogenesis and progressionMatthew E Hardee, Yiting Cao, Ping Fu, et al.
Frontiers in Oncology|June 15, 2026
Mining and analysis of adverse events for trastuzumab deruxtecan based on the FAERS databaseAnqing Zhu, Rilei Jiang, Chong Zhou, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
An ATM-PPM1D Circuit Controls the Processing and Restart of DNA Replication ForksYiting Cao, Yingzheng Wang, Jumana Badar, et al.
Chemosphere|September 4, 2022
Enhanced visible-light driven photocatalytic degradation of bisphenol A by tuning electronic structure of Bi/BiOBrQiao Wang, Yiting Cao, Yuemi Yu, et al.
Genes & Cancer|July 27, 2010
Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell MaintenanceYiting Cao, Justin D Lathia, Christine E Eyler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecanSith Sathornsumetee, Yiting Cao, Jennifer E Marcello, et al.
Cancer Cell|May 30, 2009
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cellsZhizhong Li, Shideng Bao, Qiulian Wu, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
NPJ Parkinson'S Disease|June 14, 2025
Perivascular space fluid diffusivity predicts clinical deterioration in prodromal and early-stage Parkinson's diseaseYi Xing, Miao Lin, Jingzhe Li, et al.
Cancer Research|October 19, 2005
Enhancement of cancer radiation therapy by use of adenovirus-mediated secretable glucose-regulated protein 94/gp96 expressionShanling Liu, He Wang, Zhonghui Yang, et al.
Cancer Research|April 19, 2007
Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growthYiting Cao, Pierre Sonveaux, Shanling Liu, et al.
Plos One|June 21, 2007
Erythropoietin blockade inhibits the induction of tumor angiogenesis and progressionMatthew E Hardee, Yiting Cao, Ping Fu, et al.
Frontiers in Oncology|June 15, 2026
Mining and analysis of adverse events for trastuzumab deruxtecan based on the FAERS databaseAnqing Zhu, Rilei Jiang, Chong Zhou, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
An ATM-PPM1D Circuit Controls the Processing and Restart of DNA Replication ForksYiting Cao, Yingzheng Wang, Jumana Badar, et al.
Chemosphere|September 4, 2022
Enhanced visible-light driven photocatalytic degradation of bisphenol A by tuning electronic structure of Bi/BiOBrQiao Wang, Yiting Cao, Yuemi Yu, et al.
Genes & Cancer|July 27, 2010
Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell MaintenanceYiting Cao, Justin D Lathia, Christine E Eyler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecanSith Sathornsumetee, Yiting Cao, Jennifer E Marcello, et al.
Cancer Cell|May 30, 2009
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cellsZhizhong Li, Shideng Bao, Qiulian Wu, et al.
Pageof 6